雅化集團(002497.SZ):與Pilgangoora簽署鋰輝石精礦承購協議
格隆匯3月12日丨雅化集團(002497.SZ)公佈,近日,四川雅化實業集團股份有限公司與澳大利亞鋰礦生產商Pilbara Minerals Ltd.(簡稱“Pilbara”)的全資子公司Pilgangoora Operations PtyLtd.(簡稱“Pilgangoora”)簽訂了《鋰輝石精礦承購協議》,公司將在2024年至2026年期間向Pilgangoora採購鋰輝石精礦。
根據本協議約定,Pilgangoora2024年向公司供應鋰輝石精礦2-8萬噸,2025年至2026年期間每年均向公司供應鋰輝石精礦10-16萬噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.